Viemed Healthcare (VMD) Profit After Tax Growth (3y) (2021 - 2026)
Viemed Healthcare (VMD) Profit After Tax Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 49.66% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -7.65% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.79% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 97.37% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 15.46% |
| 10 | Viemed Healthcare | 336.94 Mn | 326.26 Mn | 45.05 Mn | 7.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.57% |
| Mar 31, 2026 | 19.40% |
| Dec 31, 2025 | 40.34% |
| Sep 30, 2025 | 49.33% |
| Jun 30, 2025 | 280.49% |
| Mar 31, 2025 | 155.23% |
| Dec 31, 2024 | 2.95% |
| Sep 30, 2024 | 29.22% |
| Jun 30, 2024 | 528.42% |
| Mar 31, 2024 | -1.63% |
| Dec 31, 2023 | -11.82% |
| Sep 30, 2023 | 395.46% |
| Jun 30, 2023 | -50.67% |
| Mar 31, 2023 | 90.03% |
| Dec 31, 2022 | -4.13% |
| Sep 30, 2022 | -28.22% |
| Jun 30, 2022 | -64.56% |
| Mar 31, 2022 | -56.34% |
| Dec 31, 2021 | 11.25% |
| Sep 30, 2021 | -6.57% |